Our Differentiated Formulations efforts involve applying novel formulation and drug delivery technologies to improve or repurpose products that have a sizable track record of human clinical use. The products developed within this effort are patent-protected, and are intended to address significant clinical needs that we have identified through market research and the help of our advisors. Our efforts extend across dermatology, metabolic diseases, cardiovascular diseases, pain, inflammation, and antibacterials, and are intended to serve the needs of both major as well as emerging markets.

The research and development efforts for these Differentiated Formulations are conducted either in our laboratories in Hyderabad or with various collaboration partners around the world.

Our most advanced Differentiated Formulations efforts are in dermatology, where we have launched several effective and innovative products through our wholly owned subsidiary Promius Pharma. Headquartered in Bridgewater, New Jersey (USA), Promius Pharma is a branded specialty company with a portfolio of in licensed dermatological products and an internal pipeline of topical products in different stages of development. Promius Pharma’s current portfolio contains innovative topical products for the treatment of psoriasis, atopic dermatitis and seborrheic dermatitis.

For more information about Promius Pharma, please visit www.promiuspharma.com

Top

USP